House Committee Says Johnson & Johnson Is Dragging Its Heels On Recall Probe

NEW YORK June 11 (Reuters) - A U.S. Congressional committee investigating the recent recall of Johnson & Johnson’s (JNJ.N) children’s medicine is “deeply concerned” about the manufacturer’s cooperation, a committee spokeswoman said on Friday.